Glioma
516
126
151
170
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
57 trials with published results (11%)
Research Maturity
170 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
47 terminated out of 516 trials
78.3%
-8.2% vs benchmark
3%
16 trials in Phase 3/4
34%
57 of 170 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 170 completed trials
Clinical Trials (516)
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Tessa Jowell BRAIN MATRIX - Platform Study
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Development of MRF for Characterization of Brain Tumors After Radiotherapy
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Study of Mirdametinib in People With Central Nervous System Tumors
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)
Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared
Multimodal Machine Learning Characterization of Solid Tumors
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors